Articles
-
-
Pharmacokinetics and biodistribution of a novel anticancer thyrointegrin αvβ3 antagonist: triazole modified tetraiodothyroacetic acid conjugated to polyethylene glycol (P-bi-TAT)
-
Dawn of a new beginning
-
Utilization of risk-based predictive stability within regulatory submissions; industry’s experience
-
Similarity assessment of quality attributes of biological medicines: the calculation of operating characteristics to compare different statistical approaches
-
ANVISA: an introduction to a new regulatory agency with many challenges
-
A review of in vivo and in vitro aspects of alcohol-induced dose dumping
-
Solid form changes during drug development: good, bad, and ugly case studies
-
Drug manufacturing and access to medicines: the West African story. A literature review of challenges and proposed remediation
-
Stability challenges not addressed by harmonized guidance – AAPS workshop of the stability focus group, April 3rd- 4th, 2017 in Rockville, MD
Aims and scope
AAPS Open, an American Association of Pharmaceutical Scientists (AAPS) journal and its flagship open access title, aims to be the first global address for open access publication in the pharmaceutical sciences. AAPS Open is characterized by its rigorous but fast review timelines, breadth of article formats, and a special focus on applied sciences. View full journal scope here.
New thematic series
Drug Development Initiatives for Global Health
Edited by Paddy Shivanand and Mehran Yazdanian
Society affiliation
AAPS Open is an official journal of the American Association of Pharmaceutical Scientists.
Follow
Affiliated with
Annual Journal Metrics
-
Speed
65 days to first decision for reviewed manuscripts only
54 days to first decision for all manuscripts
112 days from submission to acceptance
24 days from acceptance to publicationUsage
33,152 Downloads
24 Altmetric Mentions
- ISSN: 2364-9534 (electronic)